Literature DB >> 22886710

Low body mass index at 3 months following adjuvant chemoradiation affects survival of postoperative locally advanced oral cavity cancer patients.

Pei-Hung Chang1, Cheng-Hsu Wang, Jen-Seng Huang, Chien-Hong Lai, Tsung-Han Wu, Yii-Jeng Lan, Jason Chien-Sheng Tsai, Eric Yen-Chao Chen, Shih-Wei Yang, Kun-Yun Yeh.   

Abstract

OBJECTIVES/HYPOTHESIS: To investigate the association between body mass index and outcomes such as recurrence and survival in postoperative locally advanced oral cavity cancer patients who underwent adjuvant chemoradiation. STUDY
DESIGN: Retrospective analysis of patient data and outcomes.
METHODS: We retrospectively analyzed the records of 61 stage III, IVA, and IVB oral cavity cancer patients who were treated with curative surgery and adjuvant chemoradiation between 2007 and 2009. Each patient's body mass index was recorded throughout the treatment duration and after its completion. The associations between demographic variables, body mass index, and survival outcomes were determined by univariate and multivariate analyses.
RESULTS: Overall, body mass index decreased throughout the chemoradiation period and reached the nadir at 3 months after completion of therapy. Univariate analysis showed that patients with body mass index <18.5 kg/m(2) at 3 months after chemoradiation had significantly higher recurrence and decreased survival rates. Multivariate analysis confirmed that body mass index <18.5 kg/m(2) at this time point is an independent predictor for recurrence (P = .039) and overall survival (P = .043).
CONCLUSIONS: Early recurrence can be predicted by malnourished status 3 months after treatment completion. Malnourishment has significant negative effects on overall survival in locally advanced postoperative oral cavity cancer patients who are undergoing adjuvant chemoradiation. After therapy is completed, nutritional guidance and care should be continued for patients with this advanced disease.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22886710     DOI: 10.1002/lary.23450

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population.

Authors:  Lisa A Peterson; Emily L Bellile; Gregory T Wolf; Shama Virani; Andrew G Shuman; Jeremy M G Taylor; Laura S Rozek
Journal:  Head Neck       Date:  2016-07-19       Impact factor: 3.147

2.  Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer.

Authors:  Pei-Hung Chang; Cheng-Hsu Wang; Eric Yen-Chao Chen; Shih-Wei Yang; Wen-Chi Chou; Jason Chia-Hsun Hsieh; Feng-Che Kuan; Kun-Yun Yeh
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

3.  Nutritional parameters associated with hospital admissions in patients being treated for head and neck cancer.

Authors:  Amanda M Duffy; Mark Halaki; Allan Spigelman; Venessa Chin; Richard M Gallagher; Victoria M Flood
Journal:  Support Care Cancer       Date:  2019-05-02       Impact factor: 3.603

4.  Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.

Authors:  Kosei Kubota; Ryohei Ito; Norihiko Narita; Yusuke Tanaka; Ken Furudate; Natsumi Akiyama; Chuang Hao Chih; Shotaro Komatsu; Wataru Kobayashi
Journal:  BMC Cancer       Date:  2022-04-07       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.